Orion Corporation

Type: Public
On the web: http://www.orion.fi
Employees: 3,309
Employee growth: 4.2%

Orion shines brightly over Scandinavia. At the heart of the health care group is Orion Pharma, one of Finland's largest drug makers. Orion Pharma manufactures prescription, generic, and OTC pharmaceuticals, as well as veterinary medicines. Its Fermion subsidiary manufactures active pharmaceutical ingredients (API) for use by Orion and other drug makers. The company's research is focused on developing treatments for central nervous system, cardiovascular, and urological disorders, as well as cancer. Orion Diagnostica develops and manufactures diagnostic tests to be used on site in physicians' offices.

Key numbers for fiscal year ending December, 2008:
Sales: $1,001.7M
One year growth: (0.4%)
Net income: $192.1M
Income growth: (10.2%)

Officers:
Chairman and CEO: Timo Lappalainen
CFO: Jari Karlson
SVP Global Sales: Pekka Kaivola

Competitors:
Merck OY
Roche Holding
Sanofi-Aventis

Orion Corporation

Type	Public (OMX: ORNBV)
Founded	1917
Headquarters	Espoo, Finland
Key people	Timo Lappalainen (President and CEO), Matti Kavetvuo (Chairman of the board)
Industry	Pharmaceutical industry
Products	Pharmaceuticals, active pharmaceutical ingredients and diagnostic tests
Revenue	€710.7 million (2008)[1]
Operating income	▲ €185.0 million (2008)[1]
Profit	▲ €136.3 million (2008)[1]
Employees	3,310 (2008)[1]
Website	www.orion.fi

Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company also has a large R&D unit in Turku.

Orion has annual net sales of approximately EUR 500 million; its class A and B shares are listed on the Helsinki Stock Exchange.

Products

Anti-diabetic drugs Glimepirid Orion (glimepiride) Metforem (metformin) Origlucon (glibenclamide) Gastric acid related drugs Ranimex (ranitidine) Zolt (lansoprazole) Oral hygiene Daktarin (miconazole) Elmex (olaflur) Motion sickness drugs Vertipam (cyclizine, diazepam and nicotinic acid) Vitamins Cohemin (cyanocobalamin) Neuramin (thiamine) Anticoagulants Marevan (warfarin) Cardiovascular drugs Digoxin (digoxin) Disomet (disopyramide) Dopmin (dopamine) Kiniduron (quinidine) Lidocard (lidocaine) Nitro (glyceryl trinitrate) Nitrosid (isosorbide dinitrate) Ormox (isosorbide mononitrate) Simdax (levosimendan) Antihypertensive drugs Amlodipin Orion (amlodipine) Carvedilol Orion Pharma (carvedilol) Dilzem (diltiazem) Escor (nilvadipine) Espesil (acebutolol) Lisipril (lisinopril) Lopril (captopril) Nifangin (nifedipine) Orloc (bisoprolol) Pinloc (pindolol) Pratsiol (pratsinolol) Propral (propranolol) Selopral (metoprolol) Verpamil (verapamil) Lisipril Comp (lisinopril and hydrochlorothiazide) Orloc Comp (bisoprolol and hydrochlorothiazide) Diuretics Diurex (hydrochlorothiazide and amiloride) Furesis (furosemide) Furesis Comp (furosemide and triamterene) Hydrex (hydrochlorothiazide) Indapamide Orion (indapamide) Spiresis (spironolactone) Uretren Comp (trichlormethiazide and triamterene) Hypolipidemic agents Atorvastatin Orion (atorvastatin) Lovacol (lovastatin) Pravastatin Orion (pravastatin) Simvastatin Orion (simvastatin)

References

1. ^ ^{a b c d} "Annual Results 2008". Orion. http://img.orion.fi/liitteet/204184.pdf. Retrieved 2009-03-09. 

External links

• Official site

v • d • e OMX Helsinki 25 companies of Finland Cargotec · Elisa · Fortum · Kesko · KONE · Konecranes · Metso · Neste Oil · Nokia · Nokian Tyres · Nordea · Orion Corporation · Outokumpu · Outotec · Pohjola Bank · Rautaruukki · Sampo · Sanoma · Stora Enso · Talvivaara Mining Company · TeliaSonera · Tieto · UPM · Wärtsilä · YIT

This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)